Progesterone inhibits endothelial cell migration through suppression of the rho activity mediated by csrc activation

Journal of Cellular Biochemistry

Volumn 116, Issue 7, 2015, Pages 1411-1418

  Lee, Tong Sheng ^a,b   Lin, Jhen Jhe ^a   Huo, Yen Nien ^a   Lee, Wen Sen ^a,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

ANGIOGENESIS; PROGESTERONE RECEPTOR; RHO PROTEINS

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; FOCAL ADHESION KINASE; MIFEPRISTONE; PAXILLIN; PROGESTERONE; PROGESTERONE RECEPTOR; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE ANTAGONIST; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE; RAC1 PROTEIN, HUMAN; RHOA PROTEIN, HUMAN;

ANTIANGIOGENIC ACTIVITY; ARTICLE; ASSAY; CELL MIGRATION; CELL MOTILITY; CELL VIABILITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FOCAL ADHESION; HUMAN; HUMAN CELL; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; WOUND HEALING ASSAY; ANTAGONISTS AND INHIBITORS; CELL MOTION; DOWN REGULATION; DRUG EFFECTS; METABOLISM;

CELL MOVEMENT; DOWN-REGULATION; HORMONE ANTAGONISTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MIFEPRISTONE; PROGESTERONE; PYRIMIDINES; RAC1 GTP-BINDING PROTEIN; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84929082567     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25101     Document Type: Article

References (34)

1. Abedi H, Zachary I,. 1995. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res 30: 544-556.
2. Abraham S, Yeo M, Montero-Balaguer M, Paterson H, Dejana E, Marshall CJ, Mavria G,. 2009. VE-cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation. Curr Biol 19: 668-674.
3. Albrecht ED, Aberdeen GW, Niklaus AL, Babischkin JS, Suresch DL, Pepe GJ,. 2003. Acute temporal regulation of vascular endothelial growth/permeability factor expression and endothelial morphology in the baboon endometrium by ovarian steroids. J Clin Endocr Metab 88: 2844-2852.
4. Arthur WT, Petch LA, Burridge K,. 2000. Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism. Curr Biol 10: 719-722.
5. Bellon G, Martiny L, Robinet A,. 2004. Matrix metalloproteinases and matrikines in angiogenesis. Crit Rev Oncol Hematol 49: 203-220.
6. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, Edwards DP,. 2001. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 28: 269-280.
7. Bussolino F, Mantovani A, Persico G,. 1997. Molecular mechanisms of blood vessel formation Trends Biochem Sci 22: 251-256.
8. Chien MH, Hsieh YS, Yeh CM, Lee WS, Chang JH, Yang SF,. 2012. Dioscorea nipponica Makino inhibits migration and invasion of human oral cancer HSC-3 cells by transcriptional inhibition of matrix metalloproteinase-2 through modulation of CREB and AP-1 activity. Food Chem Toxicol 50: 558-566.
9. Cohen LA, Guan JL,. 2005. Mechanisms of focal adhesion kinase regulation. Curr Cancer Drug Targets 5: 629-643.
10. Fritz G, Kaina B,. 1997. RhoB encoding a UV-inducible Ras-related small GTP-binding protein is regulated by GTPases of the Rho family and independent of JNK, ERK, and p38 MAP kinase. J Biol Chem 272: 30637-30644.
11. Gupta MK, Qin RY,. 2003. Mechanism and its regulation of tumor-induced angiogenesis World J Gastroenterol 9: 1144-1155.
12. Hall A,. 1998. Rho GTPases and the actin cytoskeleton. Science 279: 509-514.
13. Harris ES, Nelso WJ,. 2010. VE-cadherin: At the front, center, and sides of endothelial cell organization and function. Curr Opin Cell Biol 22: 651-658.
14. Ho PY, Zhong WB, Ho YS, Lee WS,. 2006. Terbinafine inhibits endothelial cell migration through suppression of the Rho-mediated pathway. Mol Cancer Ther 5: 3130-3138.
15. Hood JD, Cheresh DA,. 2002. Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100.
16. Hou TC, Lin JJ, Wen CH, Chen LC, Hsu SP, Lee WS,. 2013. Folic acid inhibits endothelial cell migration through inhibiting the RhoA activity mediated by activating the folic acid receptor/cSrc/p190RhoGAP-signaling pathway. Biochem Pharmacol 85: 376-384.
17. Hsu SP, Lee WS,. 2011. Progesterone receptor activation of extra-nuclear signaling pathways in regulating p53 expression in vascular endothelial cells. Mol Endocrinol 25: 421-432.
18. Hsu SP, Ho PY, Juan SH, Liang YC, Lee WS,. 2008. Progesterone inhibits human endothelial cell proliferation through a p53-dependent pathway. Cell Mol Life Sci 65: 3839-3850.
19. Kalebic T, Garbisa S, Glaser B, Liotta LA,. 1983. Basement membrane collagen: Degradation by migrating endothelial cells. Science 221: 281-283.
20. Keledjian K, Garrison JB, Kyprianou N,. 2005. Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion. J Cell Biochem 94: 374-388.
21. Lee WS, Harder JA, Yoshizumi M, Lee ME, Haber E,. 1997. Progesterone inhibits arterial smooth muscle cell proliferation. Nat Med 3: 1005-1008.
22. Lin SY, Yeh SD, Chang HC, Lin CH, Liu JD, Lee WS,. 2002. Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis. J Cell Biochem 84: 532-544.
23. McTaggart SJ,. 2006. Isoprenylated proteins. Cell Mol Life Sci 63: 255-267.
24. Nelson CM, Chen CS,. 2003. VE-cadherin simultaneously stimulates and inhibits cell proliferation by altering cytoskeletal structure and tension. J Cell Sci 116: 3571-3581.
25. Nelson CM, Pirone DM, Tan JL, Chen CS,. 2004. Vascular endothelial-cadherin regulates cytoskeletal tension, cell spreading, and focal adhesions by stimulating RhoA. Mol Biol Cell 15: 2943-2953.
26. Niklaus AL, Aberdeen GW, Babischkin JS, Pepe GJ, Albrecht ED,. 2003. Effect of estrogen on vascular endothelial growth/permeability factor expression by glandular epithelial and stromal cells in the baboon endometrium. Biol Reprod 68: 1997-2004.
27. Papetti M, Herman IM,. 2002. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282: C947-970.
28. Risau W,. 1997. Mechanisms of angiogenesis. Nature 386: 671-674.
29. Rodriguez LG, Wu X, Guan JL,. 2005. Wound-healing assay. Methods Mol Biol 294: 23-29.
30. Seabra MC,. 1998. Membrane association and targeting of prenylated Ras like GTPases. Cell Signal 10: 167-172.
31. Sengupta K, Banerjee S, Saxena N, Banerjee SK,. 2003. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway. Int J Oncol 22: 609-614.
32. Vázquez F, Rodriguez-Manzaneque JC, Lydon JP, Edwards DP, O'Malley BW, Iruela-Arispe ML,. 1999. Progesterone regulates proliferation of endothelial cells. J Biol Chem 274: 2185-2192.
33. Wheeler AP, Ridley AJ,. 2004. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 301: 43-49.
34. Wherlock M, Gampel A, Futter C, Mellor H,. 2004. Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase. J Cell Sci 117: 3221-3231.